hotspot -WSS

hotspot

author：focus 2025-10-01 00:59:04 - browse：468

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Prime Medicine says its gene editing passes test in monkeys

knowledge

WSS

DeepMind touts AlphaFold's new skills as protein folding AI models face off

What will save rural psychiatry services? Higher Medicaid payments

Prosthetic arm enables patients to feel the objects they grip

Kidney transplant patients stopped immunosuppressants in trial

Readout LOUD podcast: ESMO highlights & Roivant's big deal

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

hotspot

hotspot

hotspot

Heart attack and stroke risk calculators need revising

Coloradans with cystic fibrosis could lose access to Trikafta

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Activists slam private health insurers over coverage restrictions

Scientists successfully use ultrasound imaging to map brain activity

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

BioMarin wins approval for gene therapy to treat hemophilia A

Health insurers say they are turning to AI to cut costs, improve care

hotspot

What is microchimerism and how does it affect maternal health?

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Live blog: Hearing on CRISPR

Latest bird flu infection made farmworker sicker than earlier cases

hotspot

knowledge

focus

hotspot